Marine Gross-Goupil Selected Research

Marine Gross-Goupil Research Topics

Disease

44	Renal Cell Carcinoma (Grawitz Tumor) 07/2022 - 10/2010
17	Neoplasms (Cancer) 06/2022 - 10/2002
13	Prostatic Neoplasms (Prostate Cancer) 03/2022 - 05/2009
7	Neoplasm Metastasis (Metastasis) 12/2020 - 05/2003
5	Carcinoma (Carcinomatosis) 01/2021 - 06/2015
5	Disease Progression 09/2020 - 12/2012
3	Brain Neoplasms (Brain Tumor) 01/2022 - 12/2017
3	Urinary Bladder Neoplasms (Bladder Cancer) 10/2021 - 11/2017
3	Kidney Neoplasms (Kidney Cancer) 01/2021 - 09/2012
3	Germ Cell and Embryonal Neoplasms (Germ Cell Tumor) 01/2021 - 12/2017
3	Hepatocellular Carcinoma (Hepatoma) 08/2003 - 10/2002
2	Fatigue 03/2022 - 12/2016
2	Pain (Aches) 03/2022 - 05/2009
2	Seminoma 01/2022 - 12/2014
2	Colitis 01/2021 - 04/2017
1	Edema (Dropsy) 03/2022
1	Alopecia (Baldness) 03/2022
1	Heart Failure 01/2022
1	Thrombotic Microangiopathies 01/2022
1	Digestive System Diseases 01/2022
1	Massive Hepatic Necrosis 01/2022
1	Hypertension (High Blood Pressure) 01/2022
1	Liver Failure 01/2022
1	Sarcopenia 12/2021
1	Head and Neck Neoplasms (Head and Neck Cancer) 10/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 10/2021
1	Diarrhea 01/2021
1	Multiple Sclerosis 01/2021
1	Abdominal Pain (Pain, Abdominal) 01/2021
1	Rheumatoid Arthritis 01/2018
1	Hypesthesia (Numbness) 11/2017
1	Meningeal Carcinomatosis 11/2017
1	Non-Muscle Invasive Bladder Neoplasms 11/2017
1	Paralysis (Palsy) 11/2017
1	Pulmonary Arterial Hypertension 06/2017
1	medullary Thyroid cancer 05/2017
1	Posterior Leukoencephalopathy Syndrome 04/2017
1	Stomatitis 12/2016

Drug/Important Bio-Agent (IBA)

13	Sunitinib (Sutent)FDA Link 01/2022 - 10/2010
8	Immune Checkpoint InhibitorsIBA 01/2022 - 01/2017
8	NivolumabIBA 01/2022 - 12/2016
6	Tyrosine Kinase InhibitorsIBA 05/2022 - 02/2012
6	Docetaxel (Taxotere)FDA Link 03/2022 - 05/2009
6	Everolimus FDA Link 10/2021 - 12/2010
5	IpilimumabIBA 01/2022 - 01/2019
5	Cisplatin (Platino)FDA LinkGeneric 01/2022 - 06/2015
5	cabozantinibIBA 01/2022 - 12/2016
5	Axitinib (AG 013736)IBA 01/2020 - 02/2012
4	Carboplatin (JM8)FDA LinkGeneric 01/2022 - 12/2017
3	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 05/2022 - 12/2016
3	cabazitaxel FDA Link 03/2022 - 08/2015
3	pazopanib FDA Link 12/2021 - 12/2017
3	Angiogenesis InhibitorsIBA 12/2021 - 03/2014
3	pembrolizumabIBA 10/2021 - 10/2020
3	avelumabIBA 10/2021 - 01/2019
3	Pharmaceutical PreparationsIBA 01/2021 - 12/2017
3	MTOR InhibitorsIBA 06/2014 - 10/2011
2	Taxoids (Taxanes)IBA 03/2022 - 01/2020
2	Etoposide (VP 16)FDA LinkGeneric 01/2022 - 07/2020
2	Biomarkers (Surrogate Marker)IBA 01/2022 - 06/2015
2	LigandsIBA 10/2021 - 01/2017
2	Monoclonal AntibodiesIBA 01/2021 - 02/2014
2	Panitumumab (Vectibix)FDA Link 01/2021 - 04/2017
2	Gemcitabine FDA Link 06/2020 - 03/2007
2	Prostate-Specific Antigen (Semenogelase)IBA 01/2020 - 05/2009
2	Hormones (Hormone)IBA 01/2018 - 09/2017
2	CytokinesIBA 02/2014 - 12/2012
2	tivozanibIBA 09/2012 - 02/2012
2	taxaneIBA 01/2010 - 03/2007
2	Oxaliplatin (Eloxatin)FDA LinkGeneric 03/2007 - 04/2002
2	Messenger RNA (mRNA)IBA 08/2003 - 10/2002
1	Lipase (Acid Lipase)FDA Link 01/2022
1	ErbB Receptors (EGF Receptor)IBA 01/2021
1	Doxorubicin (Adriamycin)FDA LinkGeneric 01/2021
1	Methotrexate (Mexate)FDA LinkGeneric 01/2021
1	Vinblastine (Vinblastine Sulfate)FDA Link 01/2021
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021
1	B7-H1 AntigenIBA 10/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	cyclo(Arg-Pro) (CI 4)IBA 01/2020
1	Biological ProductsIBA 01/2020
1	atezolizumabIBA 01/2020
1	PlatinumIBA 01/2019
1	cyclic citrullinated peptideIBA 01/2018
1	Anti-Citrullinated Protein AntibodiesIBA 01/2018
1	Thyroglobulin FDA Link 11/2017
1	RadiumIBA 09/2017
1	CTLA-4 AntigenIBA 01/2017

Therapy/Procedure

33	Therapeutics 07/2022 - 02/2012
14	Drug Therapy (Chemotherapy) 03/2022 - 01/2010
12	Castration 03/2022 - 05/2009
9	Nephrectomy 06/2022 - 12/2017
2	Liver Transplantation 08/2004 - 05/2003
1	Combination Drug Therapy (Combination Chemotherapy) 10/2021
1	JET protocol 01/2021
1	Metastasectomy 01/2021
1	Duration of Therapy 01/2020
1	Art Therapy 01/2020
1	Telescopes 11/2017
1	Radiotherapy 09/2017